Postdoctoral Research Fellow
University of Sydney
Melbourne, Australia
Sally graduated from The University of Sydney, Australia in 2007 and has been a feline-only clinician since 2010. She attained memberships in feline medicine with the ANZCVS in 2012, was a director at The Cat Clinic Melbourne, an examiner with the ANZCVS, and tutors for the Centre for Veterinary Education. Since 2020, Sally has been completing a PhD investigating antiviral therapies for FIP, where she conducted a national prospective study utilizing remdesivir and GS-441524; characterized the in vitro and in vivo pharmacokinetics of remdesivir in cats with FIP; co-authored a retrospective collaborative study assessing treatment outcomes of 307 cats treated with remdesivir and GS-441524, and has presented to audiences in Australia, USA, UK and Japan.
Disclosure information not submitted.
FIP Expert Update: Current Status After A Year of Legal Therapy in the USA
Thursday, June 19, 2025
4:30 PM – 6:00 PM ET